Active substance
Potassium phosphate monobasic
- Health Canada 1
- Safety 1
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| POTASSIUM PHOSPHATE MONOBASIC INJECTION | 00711306 | 176 MG / ML | SOLUTION · INTRAVENOUS | SANDOZ CANADA INCORPORATED |
Safety signals and safety-related labeling changes
- US FDA 30 Aug 2024 POTASSIUM PHOSPHATES — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Combinations containing Potassium phosphate monobasic
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.